 NEW YORK, Jan. 06, 2021 GLOBE NEWSWIRE -- Conversion Labs, Inc. NASDAQ: CVLB, a direct-to-consumer telemedicine company, has been invited to present at H.C. Wainwrights BioConnect Conference being held virtually on January 11-14, 2021. 